FWM
GDRX icon

Focused Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Focused Wealth Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,400
Closed -$6K – 1032
2021
Q3 		$6K Hold
2,400
– – ﹤0.01% 682
2021
Q2 		$6K Sell
2,400
-8,000
-77% -$295K ﹤0.01% 683
2021
Q1 		$41K Buy
+10,400
New +$468K 0.01% 396

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Focused Wealth Management's GDRX Position: Q1 2024 in Review

Focused Wealth Management sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 30 shares — an estimated $201 sold.

Focused Wealth Management first reported a position in GDRX in Q4 2020 and held it in 13 quarters. The position peaked at $755K in Q3 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • Focused Wealth Management reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 30 GoodRx Holdings shares in Q1 2024, an estimated $201.
  • Focused Wealth Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 13 quarters.
  • Focused Wealth Management's GoodRx Holdings position peaked at $755K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.